Most Viewed Articles
Articles | Fulltext downloads | PDF downloads | Total downloads |
---|---|---|---|
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_39_2023 |
1,287 | 85,632 | 86,919 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
2,747 | 83,093 | 85,840 |
CommentaryStatus of research and publication in IndiaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_29_2023 |
2,167 | 73,318 | 75,485 |
EditorialEczema and skin allergy-focus on researchFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_29_2024 |
1,270 | 60,321 | 61,591 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
2,732 | 43,872 | 46,604 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
2,427 | 39,746 | 42,173 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_15_2024 |
1,902 | 38,489 | 40,391 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2023 |
2,168 | 36,810 | 38,978 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
1,149 | 35,117 | 36,266 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_26_2023 |
3,262 | 24,124 | 27,386 |
SymposiumInvestigations and treatment of photodermatosesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
1,576 | 20,694 | 22,270 |
Case ReportA novel pitch against the itchFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_13_2024 |
2,596 | 18,434 | 21,030 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_3_2024 |
2,195 | 18,271 | 20,466 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
4,233 | 13,773 | 18,006 |
ImageGiant fixed drug eruptionFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_47_2023 |
2,182 | 13,815 | 15,997 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_19_2024 |
1,649 | 13,140 | 14,789 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_1_2024 |
1,552 | 11,075 | 12,627 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
2,156 | 10,348 | 12,504 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_42_2023 |
1,392 | 11,019 | 12,411 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
9,965 | 1,855 | 11,820 |
SymposiumCutaneous photobiologyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
2,248 | 8,697 | 10,945 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
2,238 | 8,604 | 10,842 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_28_2023 |
2,094 | 8,214 | 10,308 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_4_2024 |
1,775 | 8,426 | 10,201 |
Review ArticleA review of comorbidities in atopic dermatitisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2024 |
3,083 | 7,053 | 10,136 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
2,416 | 7,317 | 9,733 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_31_2024 |
1,179 | 8,487 | 9,666 |
SymposiumPolymorphous light eruptionsFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
1,537 | 7,964 | 9,501 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
2,444 | 7,008 | 9,452 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
7,958 | 1,481 | 9,439 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
1,530 | 7,676 | 9,206 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_50_2023 |
3,419 | 5,593 | 9,012 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_16_2024 |
3,334 | 5,586 | 8,920 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_30_2023 |
1,676 | 7,213 | 8,889 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_21_2022 |
1,550 | 7,027 | 8,577 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_41_2024 |
1,298 | 6,782 | 8,080 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_21_2024 |
1,290 | 6,780 | 8,070 |
SymposiumChronic actinic dermatitisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
1,553 | 6,503 | 8,056 |
Review ArticleJAK inhibitors in dermatologyFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
5,609 | 1,702 | 7,311 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_20_2024 |
1,477 | 4,588 | 6,065 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
3,148 | 2,069 | 5,217 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
3,098 | 1,502 | 4,600 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
3,305 | 1,211 | 4,516 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
3,199 | 1,202 | 4,401 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_30_2024 |
1,050 | 3,043 | 4,093 |
Review ArticleDigital object identifier: What it is and why it matters?Full text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
3,127 | 913 | 4,040 |
Letter to EditorExosome therapy in atopic dermatitis – A way to look forwardFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_26_2022 |
2,001 | 1,988 | 3,989 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_3_2023 |
2,713 | 1,259 | 3,972 |
Review ArticleLigelizumab: A novel molecule in the management of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_8_2023 |
1,943 | 1,890 | 3,833 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text![]() ![]() ![]() DOI: 10.25259/IJSA_41_2023 |
1,200 | 2,622 | 3,822 |